Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small mitochondrial ribosomal subunit (mt-SSU) is the smaller component of the mitochondrial ribosome (mitoribosome), responsible for initiating and decoding mitochondrial mRNA translation encoded by mitochondrial DNA[3][1][2][4][5]. In mammals, the small subunit is designated as the 28S subunit, containing a minimized 12S rRNA and multiple nuclear-encoded mitoribosomal proteins (MRPs) with unique extensions to adapt to the mitochondrial environment[1][3]. The mt-SSU works together with the large subunit (mt-LSU, 39S in mammals) to synthesize 13 core protein components of the electron transport chain essential for oxidative phosphorylation[3][1]. Defects in mt-SSU assembly or function are associated with a variety of human diseases, especially those impacting energy-demanding tissues like heart, muscle, and brain, including Leigh syndrome, deafness, and some forms of cardiomyopathy[3]. Notes on is_incorrect: "Small mitochondrial ribosome" is not a canonical molecular target name and is ambiguous because the active complex is called the mitochondrial ribosome (mitoribosome), which has defined large (mt-LSU) and small (mt-SSU) subunits; "small mitochondrial ribosome" should instead be referred to as "small mitochondrial ribosomal subunit" (mt-SSU)[3][1]. It is not a receptor, enzyme, transporter, or classic drug target, but is a central component of mitochondrial biology and dysfunction can be pathogenic. There are currently no drugs directly targeting the mt-SSU in clinical medicine, though some antibiotics and small molecules can cause mitochondrial ribosomal dysfunction as off-target effects[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small mitochondrial ribosomal subunit (mt-SSU).